enGene Holdings Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
enGene Holdings Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2022 to Q3 2024.
  • enGene Holdings Inc. Income Tax Expense (Benefit) for the quarter ending October 31, 2024 was $19K, a 11.8% increase year-over-year.
  • enGene Holdings Inc. Income Tax Expense (Benefit) for the twelve months ending October 31, 2024 was -$19K, a 212% decline year-over-year.
  • enGene Holdings Inc. annual Income Tax Expense (Benefit) for 2024 was -$19K, a 212% decline from 2023.
  • enGene Holdings Inc. annual Income Tax Expense (Benefit) for 2023 was $17K, a 22.7% decline from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$19K $19K +$2K +11.8% Aug 1, 2024 Oct 31, 2024 10-K 2024-12-19
Q2 2024 -$21K -$29K -$29K May 1, 2024 Jul 31, 2024 10-Q 2024-09-10
Q1 2024 $8K $21K +$21K Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$13K -$30K -$30K Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $17K $17K Aug 1, 2023 Oct 31, 2023 10-K 2024-12-19
Q2 2023 $0 May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 $0 Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $0 Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.